PEDRO DE FREITAS: Open Payments
NPI 1609369115 · PALO CEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 27 payments from 14 companies in 2025. Trend: 2023 $27 · 2024 $42 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $102 |
| ABBVIE INC. | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $79 |
| Janssen Scientific Affairs, LLC | 1 | $70 |
| Tandem Diabetes Care, Inc. | 3 | $55 |
| Agios Pharmaceuticals, Inc. | 1 | $39 |
| Amgen Inc. | 2 | $35 |
| PFIZER INC. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| Lilly USA, LLC | 1 | $25 |
Products named: Rybelsus, CAPLYTA, ERLEADA, t:slim X2 Insulin Pump with Control-IQ, UBRELVY, PYRUKYND, NURTEC ODT, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
